Ziopharm Oncology
ZIOP
#8592
Rank
HK$1.45 B
Marketcap
HK$6.76
Share price
-0.88%
Change (1 day)
-74.85%
Change (1 year)

Earnings for Ziopharm Oncology (ZIOP)

Earnings in 2021 (TTM): -HK$0.7 Billion

According to Ziopharm Oncology's latest financial reports the company's current earnings are HK$3.73 Million. In 2020 the company made an earning of -HK$0.63 Billion a decrease over its 2019 earnings that were of -HK$0.45 Billion.

Earnings history for Ziopharm Oncology from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-HK$0.7 Billion11.07%
2020-HK$0.63 Billion38.89%
2019-HK$0.45 Billion7.33%
2018-HK$0.42 Billion0.77%
2017-HK$0.42 Billion-67.64%
2016-HK$1.29 Billion37.64%
2015-HK$0.94 Billion176.1%
2014-HK$0.34 Billion-24.63%
2013-HK$0.45 Billion-43.51%
2012-HK$0.8 Billion43.09%
2011-HK$0.56 Billion190.88%
2010-HK$0.2 Billion102.46%
2009-HK$94.22 Million-52.68%
2008-HK$0.2 Billion-10.33%
2007-HK$0.23 Billion15.35%
2006-HK$0.2 Billion355.36%
2005-HK$42.27 Million13788.35%
2004-HK$0.31 Million9.27%
2003-HK$0.28 Million-10.26%
2002-HK$0.32 Million-59.35%
2001-HK$0.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
HK$64.06 B-9,334.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.42 B-9,098.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-HK$21.39 Million-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-HK$2.1 Billion 202.45%๐Ÿ‡บ๐Ÿ‡ธ USA